Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523194 · ClinicalTrials.gov registry record
Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration
A clinical trial of Atherosclerosis, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT04523194: Active study of Atherosclerosis, sponsored by Massachusetts General Hospital.
NCT04523194 is a study of Atherosclerosis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 1,000 participants, roughly in line with the 1,051-participant average among 69 other Atherosclerosis trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04523194, a study of Atherosclerosis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this collaboration is to establish a multi-modality image database including coronary angiograms, optical coherence tomography (OCT), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. The main goal of this collaboration is to create a resource to promote further understanding of the pathobiology of atherosclerosis through image analysis.
Primary Outcome
MACE
Conditions Studied
Interventions
- OTHER Optical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA)
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Other
- Tsuchiura Kyodo General Hospital - Tsuchiura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2027-12 |
What the registry record for NCT04523194 still lists
NCT04523194 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,051-participant average among 69 other Atherosclerosis trials with a reported enrollment target.
The record links to 1 condition, with Atherosclerosis appearing as the primary indexed condition, and to 1 intervention - of which Optical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA) is the first listed.
NCT04523194 reports a single indexed study location in Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT04523194 about?
NCT04523194 is a clinical study titled "Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration". The purpose of this collaboration is to establish a multi-modality image database including coronary angiograms, optical coherence tomography (OCT), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. The main goal of this collaboration is to create ...
What is the current status of trial NCT04523194?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2020-11-09. Estimated completion is 2027-12.
What conditions does trial NCT04523194 study?
This clinical trial studies the following conditions: Atherosclerosis.
What interventions are being tested in trial NCT04523194?
The interventions under investigation include: Optical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA) (OTHER).
Who is sponsoring clinical trial NCT04523194?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04523194 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04523194's enrollment target sits among peer trials
1,000 16th of 69 higher than 54 of 69 other Atherosclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atherosclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
RECRUITING · Phase 4
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
-
Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI